Phadia EliA Parietal Cell Well - HSA Registration DE0508709
Access comprehensive regulatory information for Phadia EliA Parietal Cell Well in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0508709 and owned by Phadia AB. The device was registered on November 30, 2023.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
EliA Parietal Cell is intended for the in vitro quantitative measurement of IgG antibodies directed to parietal cells in human serum and plasma (heparin, citrate, EDTA) to aid in the clinical diagnosis of pernicious anemia. EliA Parietal Cell uses the EliA IgG method on the instruments Phadia 200 and Phadia 250. EliA products are to be used in clinical laboratories by trained professionals only.